Kevin D. Brandt
2021 - Xtant Medical Holdings
In 2021, Kevin D. Brandt earned a total compensation of $924K as Chief Commercial Officer at Xtant Medical Holdings, a 12% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $85,243 |
|---|---|
| Option Awards | $214,288 |
| Salary | $408,615 |
| Stock Awards | $205,878 |
| Other | $9,992 |
| Total | $924,016 |
Brandt received $408.6K in salary, accounting for 44% of the total pay in 2021.
Brandt also received $85.2K in non-equity incentive plan, $214.3K in option awards, $205.9K in stock awards and $10K in other compensation.
Rankings
In 2021, Kevin D. Brandt's compensation ranked 9,034th out of 12,405 executives tracked by ExecPay. In other words, Brandt earned more than 27.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,034 out of 12,405 | 27th |
Division Manufacturing | 4,009 out of 5,494 | 27th |
Major group Chemicals And Allied Products | 1,760 out of 2,369 | 26th |
Industry group Drugs | 1,565 out of 2,090 | 25th |
Industry Biological Products, Except Diagnostic Substances | 342 out of 452 | 24th |
Source: SEC filing on September 20, 2022.
Brandt's colleagues
We found two more compensation records of executives who worked with Kevin D. Brandt at Xtant Medical Holdings in 2021.
News
Xtant Medical Holdings CEO Sean Browne's 2022 pay jumps 28% to $1.1M
June 7, 2023
Xtant Medical Holdings CFO Greg Jensen's 2021 pay rises 11% to $955K
September 20, 2022
Xtant Medical Holdings CEO Sean Browne's 2020 pay jumps 146% to $4.5M
June 14, 2021
Xtant Medical Holdings CEO Carl O'Connell's 2018 pay jumps 224% to $1.8M
September 20, 2019